SCHEMBL24511108

SCHEMBL24511108

CCC(=O)[C@H](CO)NC(=O)[C@H](CCCCN(C)C1CC2CCC1C2)NC[C@@](C=O)(CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(C(C)(C)C)cc1

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CDYL2 Q8N8U2 7/20 0.68
CBX7 O95931 4/20 0.68
CBX8 Q9HC52 4/20 0.68
CBX4 O00257 3/20 0.68
CBX6 O95503 1/20 0.68
CBX2 Q14781 1/20 0.68
EED O75530 3/20 0.34
CDYL Q9Y232 1/20 0.33
PSMB5 P28074 1/20 0.32
CDK4 P11802 1/20 0.32
CCNA2 P20248 1/20 0.32
CCND1 P24385 1/20 0.32
CDK2 P24941 1/20 0.32
FOLH1 Q04609 2/20 0.31
CTSL P07711 1/20 0.31
PTPN2 P17706 1/20 0.31
PTPN1 P18031 1/20 0.31
CTSB P07858 2/20 0.31
OPRK1 P41145 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27232005 0.84 CDYL2 (0.89) CDYL2CBX7CBX8CBX4CBX6
SCHEMBL27223064 0.84 CDYL2 (0.89) CDYL2CBX7CBX8CBX4CBX6
SCHEMBL30315936 0.81 CDYL2 (1.00) CDYL2CBX7CBX8CBX4CBX6
SCHEMBL29613505 0.80 CDYL2 (0.91) CDYL2CBX7CBX8CBX4CBX6
SCHEMBL27223051 0.70 CDYL2 (0.59) CDYL2CBX7CBX8CBX4CBX6
SCHEMBL27232054 0.70 CDYL2 (0.59) CDYL2CBX7CBX8CBX4CBX6
SCHEMBL24510752 0.70 CDYL2 (0.78) CDYL2CBX7CBX8CBX4CBX6
SCHEMBL23815561 0.70 CDYL2 (0.78) CDYL2CBX7CBX8CBX4CBX6
SCHEMBL29613468 0.69 CDYL2 (0.71) CDYL2CBX7CBX8CBX4CBX6
SCHEMBL29613538 0.68 CDYL2 (0.70) CDYL2CBX7CBX8CBX4CBX6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022126000-A1 METHODS AND COMPOUNDS FOR MODULATING MYOTONIC DYSTROPHY 1 Design Therapeutics, Inc. (US) 2022-06-16 WO disclosed